Showing results (1211-1220 of 1,535) with videos related to

Sort By:
Pageof 154
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
International Journal of Molecular Sciences|September 28, 2024
Sperm DNA Fragmentation: Unraveling Its Imperative Impact on Male Infertility Based on Recent EvidenceSofoklis Stavros, Anastasios Potiris, Ermioni Molopodi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2017
Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trialP Christopoulos, W Engel-Riedel, C Grohé, et al.
Translational Lung Cancer Research|December 4, 2018
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and cliniciansMichael Allgäuer, Jan Budczies, Petros Christopoulos, et al.
Biochemical Pharmacology|February 19, 2018
Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacyEmma Dal Maso, Yue Zhu, Vi Pham, et al.
Neuropharmacology|October 26, 2018
Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonistsDarren M Riddy, Anna E Cook, David M Shackleford, et al.
Science Signaling|November 15, 2022
M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
Biochemical Pharmacology|January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptorChristopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Clinical Endocrinology|February 16, 2018
Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatmentA Abbara, R Islam, S A Clarke, et al.
Frontiers in Oncology|April 26, 2021
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung CancerFarastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
Pageof 154